CTCBIO Statistics

Total Valuation

CTCBIO has a market cap or net worth of KRW 151.10 billion. The enterprise value is 171.20 billion.

Market Cap	151.10B
Enterprise Value	171.20B

Important Dates

The next estimated earnings date is Thursday, March 20, 2025.

Earnings Date	Mar 20, 2025
Ex-Dividend Date	n/a

Share Statistics

CTCBIO has 23.91 million shares outstanding. The number of shares has decreased by -0.00% in one year.

Current Share Class	n/a
Shares Outstanding	23.91M
Shares Change (YoY)	-0.00%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	12.12%
Owned by Institutions (%)	0.51%
Float	13.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.09
PB Ratio	2.17
P/TBV Ratio	2.20
P/FCF Ratio	1,293.27
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-10.19
EV / Sales	1.23
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	1,465.32

Financial Position

The company has a current ratio of 1.19, with a Debt / Equity ratio of 0.43.

Current Ratio	1.19
Quick Ratio	0.64
Debt / Equity	0.43
Debt / EBITDA	n/a
Debt / FCF	280.89
Interest Coverage	-2.35

Financial Efficiency

Return on equity (ROE) is -18.98% and return on invested capital (ROIC) is -3.68%.

Return on Equity (ROE)	-18.98%
Return on Assets (ROA)	-2.72%
Return on Capital (ROIC)	-3.68%
Revenue Per Employee	558.03M
Profits Per Employee	-67.44M
Employee Count	249
Asset Turnover	0.83
Inventory Turnover	2.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -34.64% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-34.64%
50-Day Moving Average	7,304.60
200-Day Moving Average	7,750.15
Relative Strength Index (RSI)	33.53
Average Volume (20 Days)	70,057

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, CTCBIO had revenue of KRW 138.95 billion and -16.79 billion in losses. Loss per share was -702.41.

Revenue	138.95B
Gross Profit	46.60B
Operating Income	-7.26B
Pretax Income	-17.32B
Net Income	-16.79B
EBITDA	-1.73B
EBIT	-7.26B
Loss Per Share	-702.41

Full Income Statement

Balance Sheet

The company has 19.09 billion in cash and 32.82 billion in debt, giving a net cash position of -13.73 billion or -574.13 per share.

Cash & Cash Equivalents	19.09B
Total Debt	32.82B
Net Cash	-13.73B
Net Cash Per Share	-574.13
Equity (Book Value)	76.12B
Book Value Per Share	2,917.15
Working Capital	12.07B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.33 billion and capital expenditures -2.21 billion, giving a free cash flow of 116.84 million.

Operating Cash Flow	2.33B
Capital Expenditures	-2.21B
Free Cash Flow	116.84M
FCF Per Share	4.89

Full Cash Flow Statement

Margins

Gross margin is 33.54%, with operating and profit margins of -5.23% and -12.09%.

Gross Margin	33.54%
Operating Margin	-5.23%
Pretax Margin	-12.47%
Profit Margin	-12.09%
EBITDA Margin	-1.24%
EBIT Margin	-5.23%
FCF Margin	0.08%

Dividends & Yields

CTCBIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.00%
Shareholder Yield	0.00%
Earnings Yield	-11.11%
FCF Yield	0.08%

Stock Splits

The last stock split was on April 22, 2013. It was a forward split with a ratio of 1.1.

Last Split Date	Apr 22, 2013
Split Type	Forward
Split Ratio	1.1

Scores

CTCBIO has an Altman Z-Score of 1.9. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.9
Piotroski F-Score	n/a